{"id":"W4411152165","doi":"10.58931/crt.2025.2158","title":"Glucagon-like-peptide 1 (GLP-1) Receptor Agonists in Rheumatologic Disease","year":2025,"lang":"en","type":"article","venue":"Canadian rheumatology today.","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bruyère; Queensway-Carleton Hospital","funders":"","keywords":"Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Receptor; Exenatide; Glucagon-like peptide-2; Peptide; Medicine; Disease; Glucagon; Endocrinology; Internal medicine; Agonist; Chemistry; Diabetes mellitus; Pharmacology; Biochemistry; Insulin; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009673259,0.00021236,0.0005836085,0.0005864872,0.0003145468,0.0005999966,0.0003141261,0.0007562911,0.0041126],"category_scores_gemma":[0.001275699,0.00008187207,0.0003063094,0.0005573457,0.0003895485,0.0002754763,0.0003911408,0.001363884,0.0005855056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001212844,"about_ca_system_score_gemma":0.002232668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01299888,"about_ca_topic_score_gemma":0.05101736,"domain_scores_codex":[0.9996789,0.0001036183,0.00004212552,0.00001984188,0.000106617,0.00004899787],"domain_scores_gemma":[0.9994233,0.0001918026,0.0001114063,0.00001387681,0.000122309,0.0001373791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001316313,0.0003274676,0.006697262,0.003554207,0.0001649704,0.001198217,0.0001477513,0.000200536,0.001257606,0.00491233,0.08288661,0.8973367],"study_design_scores_gemma":[0.00150415,0.001061823,0.05126778,0.007126408,0.0004496046,0.005252638,0.0004270971,0.0003047842,0.0006259501,0.00444462,0.9274889,0.00004622032],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003577807,0.967109,0.0001109701,0.01472364,0.001136168,0.00001424767,0.00006971459,0.0000138497,0.01324451],"genre_scores_gemma":[0.0868943,0.8947544,0.0008621381,0.007621853,0.003891414,0.00004092645,0.0001668606,0.000007207844,0.005760826],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01299888,"threshold_uncertainty_score":0.02584642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007993316232730373,"score_gpt":0.2425667947983174,"score_spread":0.234573478565587,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}